ID

21413

Descrição

Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00511069

Link

https://clinicaltrials.gov/show/NCT00511069

Palavras-chave

Versões (1)
  1. 20/04/2017 20/04/2017 -
Transferido a

20 de abril de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Leukemia NCT00511069

Inglês

Eligibility Leukemia NCT00511069

1 Formulários  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00511069
Criteria
Descrição

Criteria

1. age >/=18 years
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
2. ph positive
Descrição

Philadelphia positive

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0457340
3. absence of a chr after 3 months on imatinib
Descrição

imatinib | Complete Hematologic Response Absent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0935989
UMLS CUI [2,1]
C4050175
UMLS CUI [2,2]
C0332197
4. loss of a previously obtained chr on imatinib alone
Descrição

imatinib | Complete Hematologic Response Obtained Previous | Complete Hematologic Response Lost

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0935989
UMLS CUI [2,1]
C4050175
UMLS CUI [2,2]
C1301820
UMLS CUI [2,3]
C0205156
UMLS CUI [3,1]
C4050175
UMLS CUI [3,2]
C0745777
5. absence of a ccgr within 12 months on imatinib alone
Descrição

imatinib | Cytogenetic Complete Response Absent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0935989
UMLS CUI [2,1]
C4050364
UMLS CUI [2,2]
C0332197
6. loss of a previously obtained ccgr on imatinib alone
Descrição

imatinib | Cytogenetic Complete Response Obtained Previous | Cytogenetic Complete Response Lost

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0935989
UMLS CUI [2,1]
C4050364
UMLS CUI [2,2]
C1301820
UMLS CUI [2,3]
C0205156
UMLS CUI [3,1]
C4050364
UMLS CUI [3,2]
C0745777
7. written informed consent
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
exclusion criteria for chronic phase patients :
Descrição

Exclusion Criteria | Chronic phase

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0457343
1. age <18
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
2. performance status (ecog/who) > 2 (see appendix 2)
Descrição

ECOG performance status | WHO performance status scale

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C1298650
3. inability to provide written informed consent
Descrição

Informed Consent Unable

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
4. pregnancy
Descrição

Pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
5. accelerated or blastic phase
Descrição

Accelerated phase | Blastic Phase

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0457345
UMLS CUI [2]
C3899938
6. formal refusal of any recommendation of a safe contraception
Descrição

Contraceptive methods Refused

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C1705116
7. alcohol or drug addiction
Descrição

Substance Dependence

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0038580
8. altered hepatic or renal function as defined by ast/alt or bilirubin > 3 times upper normal limits (unl)
Descrição

Liver function altered | Renal function altered | Aspartate aminotransferase increased | Alanine aminotransferase increased | Elevated total bilirubin

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0392747
UMLS CUI [2,1]
C0232804
UMLS CUI [2,2]
C0392747
UMLS CUI [3]
C0151904
UMLS CUI [4]
C0151905
UMLS CUI [5]
C0741494
9. serum creatinine > 265 umol/l or >3.0 mg/dl
Descrição

Creatinine measurement, serum

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
10. any other disease or condition that by the advise of the responsible physician would make the treatment dangerous for the patient or would make the patient ineligible for the study, including physical, psychiatric, social and behavioural problems.
Descrição

Disease At risk Patient | Condition At risk Patient | Disease Study Subject Participation Status Ineligibility | Condition Study Subject Participation Status Ineligibility

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C0030705
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C1444641
UMLS CUI [2,3]
C0030705
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C2348568
UMLS CUI [3,3]
C1512714
UMLS CUI [4,1]
C0348080
UMLS CUI [4,2]
C2348568
UMLS CUI [4,3]
C1512714
inclusion criteria for accelerated and blastic phase or acute lymphoblastic leukemia ph+
Descrição

Inclusion criteria | Accelerated phase | Blastic Phase | Philadelphia chromosome-positive acute lymphoblastic leukemia

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1512693
UMLS CUI [2]
C0457345
UMLS CUI [3]
C3899938
UMLS CUI [4]
C1960397
patients:
Descrição

Patients

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0030705
1. age >/=18 years
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
2. ph positive
Descrição

Philadelphia positive

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0457340
3. loss of a previous hematological response to imatinib alone, with further progression to abp (see section 14 for definitions)
Descrição

imatinib | Hematologic Response Previous | Hematologic Response Lost | Progression Accelerated phase | Progression Blastic Phase

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0935989
UMLS CUI [2,1]
C4054793
UMLS CUI [2,2]
C0205156
UMLS CUI [3,1]
C4054793
UMLS CUI [3,2]
C0745777
UMLS CUI [4,1]
C0449258
UMLS CUI [4,2]
C0457345
UMLS CUI [5,1]
C0449258
UMLS CUI [5,2]
C3899938
4. performance status (ecog/who)
Descrição

ECOG performance status | WHO performance status scale

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C1298650
5. written informed consent
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
exclusion criteria for accelerated and blastic phase or acute lymphoblastic leukemia ph+
Descrição

Exclusion Criteria | Accelerated phase | Blastic Phase | Philadelphia chromosome-positive acute lymphoblastic leukemia

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0457345
UMLS CUI [3]
C3899938
UMLS CUI [4]
C1960397
patients:
Descrição

Patients

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0030705
1. age <18
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
2. performance status (ecog/who) > 2 (see appendix 2)
Descrição

ECOG performance status | WHO performance status scale

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C1298650
3. inability to provide written informed consent
Descrição

Informed Consent Unable

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
4. pregnancy
Descrição

Pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
5. chronic phase disease
Descrição

Chronic Phase of Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1333047
6. formal refusal of any recommendation of a safe contraception
Descrição

Contraceptive methods Refused

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C1705116
7. alcohol or drug addiction
Descrição

Substance Dependence

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0038580
8. altered hepatic or renal function as defined by ast/alt or bilirubin > 3 times upper normal limits (unl)
Descrição

Liver function altered | Renal function altered | Aspartate aminotransferase increased | Alanine aminotransferase increased | Elevated total bilirubin

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0392747
UMLS CUI [2,1]
C0232804
UMLS CUI [2,2]
C0392747
UMLS CUI [3]
C0151904
UMLS CUI [4]
C0151905
UMLS CUI [5]
C0741494
9. serum creatinine > 265 umol/l or >3.0 mg/dl
Descrição

Creatinine measurement, serum

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
10. any other disease or condition that by the advise of the responsible physician would make the treatment dangerous for the patient or would make the patient ineligible for the study, including physical, psychiatric, social and behavioural problems.
Descrição

Disease At risk Patient | Condition At risk Patient | Disease Study Subject Participation Status Ineligibility | Condition Study Subject Participation Status Ineligibility

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C0030705
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C1444641
UMLS CUI [2,3]
C0030705
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C2348568
UMLS CUI [3,3]
C1512714
UMLS CUI [4,1]
C0348080
UMLS CUI [4,2]
C2348568
UMLS CUI [4,3]
C1512714
Voltar ao início da página

Similar models

Eligibility Leukemia NCT00511069

1 Formulários
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00511069
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Age
Item
1. age >/=18 years
boolean
C0001779 (UMLS CUI [1])
Philadelphia positive
Item
2. ph positive
boolean
C0457340 (UMLS CUI [1])
imatinib | Complete Hematologic Response Absent
Item
3. absence of a chr after 3 months on imatinib
boolean
C0935989 (UMLS CUI [1])
C4050175 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
imatinib | Complete Hematologic Response Obtained Previous | Complete Hematologic Response Lost
Item
4. loss of a previously obtained chr on imatinib alone
boolean
C0935989 (UMLS CUI [1])
C4050175 (UMLS CUI [2,1])
C1301820 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
C4050175 (UMLS CUI [3,1])
C0745777 (UMLS CUI [3,2])
imatinib | Cytogenetic Complete Response Absent
Item
5. absence of a ccgr within 12 months on imatinib alone
boolean
C0935989 (UMLS CUI [1])
C4050364 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
imatinib | Cytogenetic Complete Response Obtained Previous | Cytogenetic Complete Response Lost
Item
6. loss of a previously obtained ccgr on imatinib alone
boolean
C0935989 (UMLS CUI [1])
C4050364 (UMLS CUI [2,1])
C1301820 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
C4050364 (UMLS CUI [3,1])
C0745777 (UMLS CUI [3,2])
Informed Consent
Item
7. written informed consent
boolean
C0021430 (UMLS CUI [1])
Exclusion Criteria | Chronic phase
Item
exclusion criteria for chronic phase patients :
boolean
C0680251 (UMLS CUI [1])
C0457343 (UMLS CUI [2])
Age
Item
1. age <18
boolean
C0001779 (UMLS CUI [1])
ECOG performance status | WHO performance status scale
Item
2. performance status (ecog/who) > 2 (see appendix 2)
boolean
C1520224 (UMLS CUI [1])
C1298650 (UMLS CUI [2])
Informed Consent Unable
Item
3. inability to provide written informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Pregnancy
Item
4. pregnancy
boolean
C0032961 (UMLS CUI [1])
Accelerated phase | Blastic Phase
Item
5. accelerated or blastic phase
boolean
C0457345 (UMLS CUI [1])
C3899938 (UMLS CUI [2])
Contraceptive methods Refused
Item
6. formal refusal of any recommendation of a safe contraception
boolean
C0700589 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Substance Dependence
Item
7. alcohol or drug addiction
boolean
C0038580 (UMLS CUI [1])
Liver function altered | Renal function altered | Aspartate aminotransferase increased | Alanine aminotransferase increased | Elevated total bilirubin
Item
8. altered hepatic or renal function as defined by ast/alt or bilirubin > 3 times upper normal limits (unl)
boolean
C0232741 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
C0741494 (UMLS CUI [5])
Creatinine measurement, serum
Item
9. serum creatinine > 265 umol/l or >3.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
Disease At risk Patient | Condition At risk Patient | Disease Study Subject Participation Status Ineligibility | Condition Study Subject Participation Status Ineligibility
Item
10. any other disease or condition that by the advise of the responsible physician would make the treatment dangerous for the patient or would make the patient ineligible for the study, including physical, psychiatric, social and behavioural problems.
boolean
C0012634 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C0030705 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C2348568 (UMLS CUI [3,2])
C1512714 (UMLS CUI [3,3])
C0348080 (UMLS CUI [4,1])
C2348568 (UMLS CUI [4,2])
C1512714 (UMLS CUI [4,3])
Inclusion criteria | Accelerated phase | Blastic Phase | Philadelphia chromosome-positive acute lymphoblastic leukemia
Item
inclusion criteria for accelerated and blastic phase or acute lymphoblastic leukemia ph+
boolean
C1512693 (UMLS CUI [1])
C0457345 (UMLS CUI [2])
C3899938 (UMLS CUI [3])
C1960397 (UMLS CUI [4])
Patients
Item
patients:
boolean
C0030705 (UMLS CUI [1])
Age
Item
1. age >/=18 years
boolean
C0001779 (UMLS CUI [1])
Philadelphia positive
Item
2. ph positive
boolean
C0457340 (UMLS CUI [1])
imatinib | Hematologic Response Previous | Hematologic Response Lost | Progression Accelerated phase | Progression Blastic Phase
Item
3. loss of a previous hematological response to imatinib alone, with further progression to abp (see section 14 for definitions)
boolean
C0935989 (UMLS CUI [1])
C4054793 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C4054793 (UMLS CUI [3,1])
C0745777 (UMLS CUI [3,2])
C0449258 (UMLS CUI [4,1])
C0457345 (UMLS CUI [4,2])
C0449258 (UMLS CUI [5,1])
C3899938 (UMLS CUI [5,2])
ECOG performance status | WHO performance status scale
Item
4. performance status (ecog/who)
boolean
C1520224 (UMLS CUI [1])
C1298650 (UMLS CUI [2])
Informed Consent
Item
5. written informed consent
boolean
C0021430 (UMLS CUI [1])
Exclusion Criteria | Accelerated phase | Blastic Phase | Philadelphia chromosome-positive acute lymphoblastic leukemia
Item
exclusion criteria for accelerated and blastic phase or acute lymphoblastic leukemia ph+
boolean
C0680251 (UMLS CUI [1])
C0457345 (UMLS CUI [2])
C3899938 (UMLS CUI [3])
C1960397 (UMLS CUI [4])
Patients
Item
patients:
boolean
C0030705 (UMLS CUI [1])
Age
Item
1. age <18
boolean
C0001779 (UMLS CUI [1])
ECOG performance status | WHO performance status scale
Item
2. performance status (ecog/who) > 2 (see appendix 2)
boolean
C1520224 (UMLS CUI [1])
C1298650 (UMLS CUI [2])
Informed Consent Unable
Item
3. inability to provide written informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Pregnancy
Item
4. pregnancy
boolean
C0032961 (UMLS CUI [1])
Chronic Phase of Disease
Item
5. chronic phase disease
boolean
C1333047 (UMLS CUI [1])
Contraceptive methods Refused
Item
6. formal refusal of any recommendation of a safe contraception
boolean
C0700589 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Substance Dependence
Item
7. alcohol or drug addiction
boolean
C0038580 (UMLS CUI [1])
Liver function altered | Renal function altered | Aspartate aminotransferase increased | Alanine aminotransferase increased | Elevated total bilirubin
Item
8. altered hepatic or renal function as defined by ast/alt or bilirubin > 3 times upper normal limits (unl)
boolean
C0232741 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
C0741494 (UMLS CUI [5])
Creatinine measurement, serum
Item
9. serum creatinine > 265 umol/l or >3.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
Disease At risk Patient | Condition At risk Patient | Disease Study Subject Participation Status Ineligibility | Condition Study Subject Participation Status Ineligibility
Item
10. any other disease or condition that by the advise of the responsible physician would make the treatment dangerous for the patient or would make the patient ineligible for the study, including physical, psychiatric, social and behavioural problems.
boolean
C0012634 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C0030705 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C2348568 (UMLS CUI [3,2])
C1512714 (UMLS CUI [3,3])
C0348080 (UMLS CUI [4,1])
C2348568 (UMLS CUI [4,2])
C1512714 (UMLS CUI [4,3])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial